Warning Letter Wednesday Posts
A weekly exploration of FDA warning letters and enforcement trends
Takeaway -
Blogs on a commercial website are marketing claims
Takeaway -
Everything used to market products must be compliant
Takeaway -
Blogs can easily cross the line from “education” to “disease claims”
Takeaway -
All social media is “fair game” for enforcement
Takeaway -
Uncompliant hashtags attract FDA attention
Takeaway -
Citing clinical studies on a commercial website is high risk
Takeaway -
Product reviews must be honest and truthful
Takeaway -
Remove high-risk claims in all marketing materials
Takeaway -
Replace high-risk words on a commercial website
Takeaway -
Use caution when promoting blood sugar products. Remove claims on social media.
Takeaway -
Hashtags can make compliant posts very non-compliant